Systeme zur Verwendung Während eines Leitungslosen Herzschrittmacherimplantatverfahrens
Anmelder: Pacesetter, Inc. 🇺🇸
Details
- Veröffentlichungs-Nr.
- EP4744585
- Anmeldetag
- 13. November 2025
- Veröffentlichung
- 20. Mai 2026
- Rechtsraum
- EP
Abstract
A system (100) and computer readable medium for use during an implant procedure during which a delivery system (100) is being used to implant a leadless pacemaker (LP) (102a, 102b) within a patient may, while the delivery system (100) is being used to position the LP (102a, 102b) at a potential implant site within the patient: receive, from the LP (102a, 102b), data comprising one or more pacing impedance measurements and at least one measurement obtained by the LP (102a, 102b) other than pacing impedance; provide the data to a model (950) that is produced prior to the implant procedure based on data collected from other LPs implanted in other patients; and use the model (950) to output an indication of whether the LP (102a, 102b) should be chronically implanted at the potential implant site.
Anmelder
- Firma
- Pacesetter, Inc.
- Land
- 🇺🇸 USA
US-amerikanisches Unternehmen der Medizintechnik, historisch Hersteller von Herzschrittmachern und implantierbaren Defibrillatoren, später Teil von Abbotts Herzrhythmus-Sparte.
196 Patente in unserer Datenbank
Vertreten von
-
Barker Brettell Sweden AB
Barker Brettell Sweden AB · Stockholm